Optimising the <scp>CamAPS FX</scp> automated insulin delivery system for exercise and complex meals in adolescents with type 1 diabetes: A prospective interventional study in a camp setting

A.E.S. is on the advisory board of Abbott, Medtronic, Movi, Sanofi, Theras and University Bocconi; has received travel grants from Ypsomed and Abbott. M.M. has received honoraria for lectures from Theras, Novo Nordisk, Ypsomed, and Medtronic, has been supported for attending meetings from Movi and Abbott, and has participated in data monitoring for Movi. O.M. has received clinical trial support: Sêr Cymru II COFUND, Fellowship/European Union, Novo Nordisk A/S, Novo Nordisk AT, Abbott Diabetes Care, Sanofi, Dexcom, Team Novo Nordisk, SAIL, Maisels Brauerei, Medtronic AT, EFSD/EASD, Falke, BISp, perfood, Ypsomed, Sinocare, Roche; presenters' honoraria: Medtronic AT, Medtronic Int., Eli Lilly, Novo Nordisk, Sanofi, TAD Pharma, ADA, Diatec, Berufsverband deutscher Internist*innen, Dexcom, Astra Zeneca, Ypsomed, Insulet, Diabetologen Hessen, Abbott; conference travel support: Novo Nordisk A/S, Novo Nordisk AT, Novo Nordisk UK, Medtronic AT, Sanofi, EASD, OEDG, DDG; advisory board: Sanofi, TAD Pharma, Dexcom, perfood, Medtronic, mySugr GmbH, Hedia. B.B. has received grants from Movi and Abbott. R.F. has received travel grants from Movi. C.M. has received travel grants from Ypsomed. E.M. has received payment to her department for educational events from Medtronic; travel grants from Movi, Abbott and Theras; advisory board from Sanofi. B.P. has received a travel grant from Movi and speaker's honoraria from Movi. I.R. has received grants to the author or organisation from Sanofi and Medtronic, and personal fees (e.g., honoraria, consulting fees, lecture fees) from Sanofi, Theras, Menarini, Movi. F.A.D., D.L.P., G.M., A.R., V.T., D.T., and S.T. have no conflicts of interest to declare. All authors declare they have no conflict of interest to disclose related to the present study, its data collection, analysis and presentation. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70295. Andrea E. Scaramuzza is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Data are available upon reasonable request made by email to the corresponding author with the aim of the request. Data S1. Supporting Information. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2025-11-20
DOI
https://doi.org/10.1111/dom.70295
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimising the CamAPS FX automated insulin delivery system for exercise and complex meals in adolescents with type 1 diabetes: A prospective interventional study in a camp setting

Andrea Scaramuzza, Barbara Predieri, Federico Abate Daga, Davide Tinti et al.
Diabetes Obesity and Metabolism
Diabetes Management and Research
article

Optimising the CamAPS FX automated insulin delivery system for exercise and complex meals in adolescents with type 1 diabetes: A prospective interventional study in a camp setting

Andrea Scaramuzza, Barbara Predieri, Federico Abate Daga, Davide Tinti, Ivana Rabbone, Othmar Moser, Bruno Bombaci, Andrea Rigamonti, Roberto Franceschi, Sonia Toni, Gianluca Musolino, Valentina Tiberi, Enza Mozzillo, Marco Marigliano, Donatella Lo Presti, Carlo Moretti
article en

Abstract

A.E.S. is on the advisory board of Abbott, Medtronic, Movi, Sanofi, Theras and University Bocconi; has received travel grants from Ypsomed and Abbott. M.M. has received honoraria for lectures from Theras, Novo Nordisk, Ypsomed, and Medtronic, has been supported for attending meetings from Movi and Abbott, and has participated in data monitoring for Movi. O.M. has received clinical trial support: Sêr Cymru II COFUND, Fellowship/European Union, Novo Nordisk A/S, Novo Nordisk AT, Abbott Diabetes Care, Sanofi, Dexcom, Team Novo Nordisk, SAIL, Maisels Brauerei, Medtronic AT, EFSD/EASD, Falke, BISp, perfood, Ypsomed, Sinocare, Roche; presenters' honoraria: Medtronic AT, Medtronic Int., Eli Lilly, Novo Nordisk, Sanofi, TAD Pharma, ADA, Diatec, Berufsverband deutscher Internist*innen, Dexcom, Astra Zeneca, Ypsomed, Insulet, Diabetologen Hessen, Abbott; conference travel support: Novo Nordisk A/S, Novo Nordisk AT, Novo Nordisk UK, Medtronic AT, Sanofi, EASD, OEDG, DDG; advisory board: Sanofi, TAD Pharma, Dexcom, perfood, Medtronic, mySugr GmbH, Hedia. B.B. has received grants from Movi and Abbott. R.F. has received travel grants from Movi. C.M. has received travel grants from Ypsomed. E.M. has received payment to her department for educational events from Medtronic; travel grants from Movi, Abbott and Theras; advisory board from Sanofi. B.P. has received a travel grant from Movi and speaker's honoraria from Movi. I.R. has received grants to the author or organisation from Sanofi and Medtronic, and personal fees (e.g., honoraria, consulting fees, lecture fees) from Sanofi, Theras, Menarini, Movi. F.A.D., D.L.P., G.M., A.R., V.T., D.T., and S.T. have no conflicts of interest to declare. All authors declare they have no conflict of interest to disclose related to the present study, its data collection, analysis and presentation. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70295. Andrea E. Scaramuzza is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Data are available upon reasonable request made by email to the corresponding author with the aim of the request. Data S1. Supporting Information. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Diabetes Obesity and MetabolismVol. 28(2)
University of Messina (IT), University of Verona (IT), University of Modena and Reggio Emilia (IT), Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT), Vita-Salute San Raffaele University (IT), University of Graz (AT), University of Trento (IT), Medical University of Graz (AT), Ospedale Filippo Del Ponte Varese (IT), San Raffaele University of Rome (IT), University of Catania (IT), Graz University of Technology (AT), 5T Torino (Italy) (IT), Northwest Women's and Children's Hospital (CN), Ospedali Riuniti di Ancona (IT), Meyer Children's Hospital (IT), Federico II University Hospital (IT), Azienda Ospedale - Università Padova (IT), Istituti Ospitalieri di Cremona (IT), Azienda Socio Sanitaria Territoriale di Cremona, University of Turin (IT), University of Naples Federico II (IT)
Eli Lilly and Company, Sanofi, Insulet Corporation, Dexcom, European Commission, European Foundation for the Study of Diabetes, Novo Nordisk, Bundesinstitut für Sportwissenschaft, European Association for the Study of Diabetes, Abbott Diabetes Care
Openalex Percentile: Top 52%
Diabetes Management and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.